000 | 06176cam a2200709Mi 4500 | ||
---|---|---|---|
001 | ocn890162866 | ||
003 | OCoLC | ||
005 | 20190328114808.0 | ||
006 | m o d | ||
007 | cr ||||||||||| | ||
008 | 140915s2014 enk o 000 0 eng d | ||
010 | _a 2014950424 | ||
040 |
_aUKMGB _beng _erda _epn _cUKMGB _dN$T _dOPELS _dYDXCP _dCHVBK _dOCLCF _dIDEBK _dEBLCP _dOCLCQ _dCNCGM _dMERER _dOCLCQ _dOCLCO _dITD _dOCLCO _dOCLCQ _dU3W _dD6H _dOCLCQ _dOTZ _dWYU _dLOA _dCUY _dZCU _dUSU _dMERUC _dOCLCO _dICG _dK6U _dCOCUF _dOCLCQ _dVT2 _dDKC |
||
016 | 7 |
_a016869524 _2Uk |
|
016 | 7 |
_a016856985 _2Uk |
|
019 |
_a898422306 _a1066443727 _a1088966405 |
||
020 |
_a9781908818683 _q(electronic bk.) |
||
020 |
_a1908818689 _q(electronic bk.) |
||
020 |
_z9781907568473 _q(hbk.) |
||
020 | _z1907568476 (print) | ||
035 |
_a(OCoLC)890162866 _z(OCoLC)898422306 _z(OCoLC)1066443727 _z(OCoLC)1088966405 |
||
050 | 4 |
_aRC661.I6 _bS66 2014 |
|
060 | 0 | 0 | _a2015 A-997 |
060 | 1 | 0 | _aWK 820 |
072 | 7 |
_aHEA _x039000 _2bisacsh |
|
072 | 7 |
_aMED _x014000 _2bisacsh |
|
072 | 7 |
_aMED _x022000 _2bisacsh |
|
072 | 7 |
_aMED _x112000 _2bisacsh |
|
072 | 7 |
_aMED _x045000 _2bisacsh |
|
082 | 0 | 4 |
_a616.462061 _223 |
100 | 1 |
_aSonia, Thundiparambil Azeez, _eauthor. |
|
245 | 1 | 0 |
_aOral delivery of insulin / _h[electronic resource] _cThundiparambil Azeez Sonia, Chandra P. Sharma. |
264 | 1 |
_aOxford : _bWoodhead Publishing, _c2014. |
|
300 | _a1 online resource. | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 1 |
_aWoodhead publishing series in biomedicine ; _vnumber 41 |
|
588 | 0 | _aCIP data; item not viewed. | |
520 | _aDiabetes Mellitus, a syndrome of disordered metabolism, characterised by abnormal elevation in blood glucose level, has become a life-threatening condition for many people. Current means of therapy for Diabetes Mellitus do not mimic the normal physiological pattern of insulin release. Oral delivery is the preferred route of administration due to its non-invasive nature. Oral delivery of insulin presents an overview of Diabetes Mellitus, and discusses the strategies and techniques adopted for oral delivery of insulin. This title begins with an introductory chapter on symptoms, complications and therapy for Diabetes Mellitus. Subsequent chapters cover the various routes for administering insulin; the challenges and strategies of oral delivery; experimental techniques in the development of an oral insulin carrier; lipids; inorganic nanoparticles and polymers in oral insulin delivery; and a summary and presentation of future perspectives on oral delivery of insulin. | ||
505 | 0 | 0 |
_gMachine generated contents note: _g1. _tDiabetes mellitus -- an overview -- _g1.1. _tDiabetes mellitus -- an introduction -- _g1.2. _tGlucose homeostasis -- _g1.3. _tTypes of diabetes -- _g1.4. _tSymptoms of diabetes -- _g1.5. _tComplications of diabetes -- _g1.6. _tDiagnosis of diabetes mellitus -- _g1.7. _tTherapy for diabetes -- _g1.8. _tNon-insulin treatment options of type 1 diabetes -- _g1.9. _tTreatment options of type 2 diabetes -- _g1.10. _tConclusion -- _g1.11. _tReferences -- _g2. _tRoutes of administration of insulin -- _g2.1. _tCurrent approach for the delivery of insulin -- _g2.2. _tRoutes of administration of insulin -- _g2.3. _tConclusion -- _g2.4. _tReferences -- _g3. _tOral insulin delivery -- challenges and strategies -- _g3.1. _tOral delivery of insulin -- _g3.2. _tBarriers to oral delivery of insulin -- _g3.3. _tStrategies and alternatives to improve oral insulin delivery -- _g3.4. _tConclusion -- _g3.5. _tReferences -- _g4. _tExperimental techniques involved in the development of oral Insulin carriers -- _g4.1. _tIntroduction -- _g4.2. _tPolymeric nanoparticles -- _g4.3. _tPhysicochemical characterization of nanoparticles -- _g4.4. _tBiological evaluation -- _g4.5. _tIn vitro method for assessing drug permeability -- _g4.6. _tIn vivo study of oral insulin -- _g4.7. _tBiodistribution studies -- _g4.8. _tConclusion -- _g4.9. _tReferences -- _g5. _tLipids and inorganic nanoparticles in oral insulin delivery -- _g5.1. _tLipid-based systems for oral delivery of insulin -- _g5.2. _tLiposomes -- _g5.3. _tSolid lipid nanoparticles -- _g5.4. _tNanostructured lipid carriers -- _g5.5. _tNiosomes -- _g5.6. _tArchaeosomes -- _g5.7. _tCubic nanoparticles (cubosomes) -- _g5.8. _tAquasomes -- _g5.9. _tInorganic nanoparticles as carriers for oral insulin delivery -- _g5.10. _tConclusion -- _g5.11. _tReferences -- _g6. _tPolymers in oral insulin delivery -- _g6.1. _tIntroduction -- _g6.2. _tCharacteristics of an ideal oral insulin carrier -- _g6.3. _tPolymers in oral insulin delivery -- _g6.4. _tNatural polymers -- _g6.5. _tSynthetic polymers -- _g6.6. _tConclusion -- _g6.7. _tReferences -- _g7. _tSummary and future perspectives for oral insulin delivery -- _g7.1. _tIntroduction -- _g7.2. _tTechnologies developed for clinical applications of oral insulin delivery -- _g7.3. _tConclusions and future perspectives -- _g7.4. _tReferences. |
504 | _aIncludes bibliographical references and index. | ||
650 | 0 |
_aInsulin _xTherapeutic use _xAdministration. |
|
650 | 0 |
_aDiabetes _xOral therapy. |
|
650 | 7 |
_aHEALTH & FITNESS _xDiseases _xGeneral. _2bisacsh |
|
650 | 7 |
_aMEDICAL _xClinical Medicine. _2bisacsh |
|
650 | 7 |
_aMEDICAL _xDiseases. _2bisacsh |
|
650 | 7 |
_aMEDICAL _xEvidence-Based Medicine. _2bisacsh |
|
650 | 7 |
_aMEDICAL _xInternal Medicine. _2bisacsh |
|
650 | 7 |
_aDiabetes _xOral therapy. _2fast _0(OCoLC)fst00892178 |
|
650 | 7 |
_aInsulin _xTherapeutic use _xAdministration. _2fast _0(OCoLC)fst00974518 |
|
650 | 1 | 2 |
_aInsulin _xadministration & dosage. _0(DNLM)D007328Q000008 |
650 | 1 | 2 |
_aAdministration, Oral. _0(DNLM)D000284 |
650 | 2 | 2 |
_aDrug Delivery Systems. _0(DNLM)D016503 |
655 | 4 | _aElectronic books. | |
655 | 0 | _aElectronic book. | |
655 | 7 |
_aElectronic books. _2lcgft |
|
700 | 1 |
_aSharma, Chandra P., _eauthor. |
|
776 | 0 | 8 |
_iPrint version: _aSharma, C.P. _tOral delivery of insulin. _dCambridge : Woodhead, 2014 _z9781907568473 _w(DLC) 2014950424 _w(OCoLC)876802531 |
830 | 0 |
_aWoodhead Publishing series in biomedicine ; _vno. 41. _x2050-0289 |
|
856 | 4 | 0 |
_3ScienceDirect _uhttp://www.sciencedirect.com/science/book/9781907568473 |
999 |
_c246954 _d246954 |